These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1973460

  • 1. Do we need a new classification of beta-blockers?
    Kendall MJ.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
    [Abstract] [Full Text] [Related]

  • 2. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM.
    J Pharmacol; 1985 Jun; 16 Suppl 2():95-108. PubMed ID: 2867254
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD, Shah SV.
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of third-generation beta-blockers: greater benefits, fewer risks.
    Kendall MJ.
    J Cardiovasc Pharmacol; 1989 Jun; 14 Suppl 7():S4-8. PubMed ID: 2481789
    [Abstract] [Full Text] [Related]

  • 6. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K, Lindner W.
    Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978
    [Abstract] [Full Text] [Related]

  • 7. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P, Rost R, Reinke A, Nagel N, Merten U.
    Arzneimittelforschung; 1985 Apr 15; 35(2):522-9. PubMed ID: 2859861
    [Abstract] [Full Text] [Related]

  • 8. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA.
    Clin Physiol Biochem; 1990 Apr 15; 8 Suppl 2():18-27. PubMed ID: 1982758
    [Abstract] [Full Text] [Related]

  • 9. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR.
    Postgrad Med; 2009 May 15; 121(3):90-8. PubMed ID: 19491545
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
    Shand DG.
    Circulation; 1983 Jun 15; 67(6 Pt 2):I2-5. PubMed ID: 6133642
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Preoperative treatment with beta-receptor blockers and isoflurane anesthesia. Hemodynamic interactions in patients with coronary disease].
    Eichwede F, Komar K, Müller R, Grote B, Tarnow J.
    Anaesthesist; 1990 Jul 15; 39(7):361-6. PubMed ID: 1974748
    [Abstract] [Full Text] [Related]

  • 13. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F, Ragot S, Julien J, Herpin D.
    Arch Mal Coeur Vaiss; 2005 Sep 15; 98(9):881-8. PubMed ID: 16231574
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ, Dietz R.
    Z Kardiol; 1997 Jan 15; 86(1):1-8. PubMed ID: 9133118
    [Abstract] [Full Text] [Related]

  • 15. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 15; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Dec 15; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 17. Beta-blockers in hypertension.
    Hansson L.
    J Hypertens Suppl; 1987 Aug 15; 5(3):S61-7. PubMed ID: 2889813
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A, Baubion N, Delage F.
    J Pharmacol; 1983 Aug 15; 14 Suppl 2():169-75. PubMed ID: 6138466
    [Abstract] [Full Text] [Related]

  • 20. Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment.
    Dahlöf C, Dimenäs E, Kendall M, Wiklund I.
    Circulation; 1991 Dec 15; 84(6 Suppl):VI108-18. PubMed ID: 1683605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.